concentration) (MIC) concentrations of penicillin G were more susceptible to killing by normal neutrophils than untreated bacteria (intracellular survival 0.17+0.04 vs. 1.5+0.38%, mean±+SEM, respectively, at 35 min in 14 experiments; P < 0.01 by t test). Furthermore, this enhanced susceptibility to killing was observed even when phagosome formation was inhibited by cytochalasin B (65.6+±4.6% pencillintreated vs. 30.5+4.5% untreated killed at 30 min in 14 experiments, P < 0.001). Pretreatment of S. aureus with vancomycin similarly enhanced susceptibility to killing by cytochalasin B-treated polymorphonuclear leukocytes (PMN), whereas pretreatment with gentamicin did not.
The enchancement of killing by pretreatment with cell wall-active antibiotics was present in a doseresponse fashion to 1/16th the MIC. It required specific antimicrobial activity; i.e., penicillin activity was inhibited by penicillinase or by incubation with bacteria at 4°C. It also required active cellular metabolism and intact neutrophils. For antibioticpretreated bacteria to be killed by normal and cytochalasin B-treated cells, phagocytosis or binding to the cells was essential via a serum opsonindependent mechanism. In experiments with the cytochalasin B-treated cells, all bound penicillin-treated bacteria were killed vs. only a fraction (70%) of the bound untreated bacteria. Penicillin in 10 times the INTRODUCTION During the treatment of bacterial infection with antimicrobials, an important interaction must occur between the drug administered and the defenses of the host to eradicate the invading bacteria. Much has been learned about the action of antimicrobials on microorganisms (1, 2) , and the mechanisms involved in the opsonization, phagocytosis, and killing of bacteria have been characterized to a great extent (3, 4) . Relatively little is known, however, whether specific antimicrobials alter the encounter between phagocytes and bacteria by modifying the surface or other properties of the organisms.
With these points in mind the present investigations were undertaken. It was postulated that those compounds that modified the bacterial cell surface would be more likely to affect the processes of phagocytosis and killing by human granulocytes (PMN)l than any that have a subcellular locus of action. Since concentrations of antimicrobials that are subinhibitory with respect to growth and killing of bacteria may modify bacterial structure and physiology ' Abbreviations used ini this paper: DMSO, dimethyl sulfox-Serum. Normal humiian serum was obtained from the clotted blood of healthy consenting volunteers, pooled, separated into aliquots, and stored at -70°C until used.
Leukocyte preparationt. PMN were separated from the heparinized (10 U/ml) peripheral blood of healthy consenting volunteers. The blood was processed either by dextran sedimentationi or by Ficoll-Hypaque and dextran sedimentation, with hypotonic lysis of the erythrocytes as previously described (9) . The cells were washed in modified Hank's solution (9) , centrifuged at 150 g for 7 min at 4°C, eiiumerated by hemocytometer, and resuspended in antibiotic-free HBSS to a fiiial concenitrationi of 5 x 106/ml. PMN comprised 80-95% of the final cell population anid constituted 98% of the phagocytic cells.
Preparationi of S. aureus. Samples taken from stock cuiltures (1/100 dilution) vere incubated in fresh TSB at 37°C for 2 h to place the bacteria in the logarithmic phase of growth. At this point, the bacterial suspension was divided into two equal aliquots and the antibiotics to be tested were added to one (final concenitrations 1/4 to 1/32 of the MIC), an(d sterile ITSB to the other (conitrol). Both bacterial suspensionis were allowed to grow for another 2 h. At the end of that period, the bacteria were removed from the antibiotic-containing broth by centrifugation at 2,200g for 10 min., washed by suspension in MHS, recentrifuged, and finally resuspended in HBSS. They were adjusted to -2.5 x 108 ml after gentle sonication (20, Bactericidal assays. 1-ml suspensions containing 2.5 x 106 PMN and 2.5 x 107 bacteria were incubated in HBSS at 37°C in the presence of 10% serum as a source of opsonins. When cytochalasin B was used, the cells were preincubated with 5 ,mg/ml ofthe compound for 10 min at 37°C before the addition of the bacteria.
Initial samples (0 time) were taken immediately after addition of the bacteria to the tubes, which were then capped and rotated at 37°C. Killing of the inoculum was measured at various times by a previously described method (10) . In experiments with noncytochalasin B-treated cells, lysostaphin was added at the end of a 25-min incubation period in a concentration of 10 U/ml for 10 min to kill extracellular bacteria. The percent survival was calculated by dividing the number of colony-forming units at various times by the number at 0 min and multiplying by 100. From this figure the percent killing could be calculated by subtraction from 100.
Phagocytosis assays. The association (binding plus phagocytosis) of viable 14C-labeled staphylococci with the cells was assessed as previously described (9, 11) . Leukocytes in a final concentration of 2.5 x 106/ml were placed in 12 x 75-mm glass borosilicate tubes with HBSS and 10% serum for opsonization. After preincubation for 10 min at 37°C, bacterial suspensions (2.5 x 107) were added to the mixture at 20-s intervals. The capped tubes were allowed to rotate for 30-min, at which time phagocytosis was stopped by flooding the suspensions with 2 ml of ice-cold HBSS containing 10% fetal calf serum and 0.2 M NaF and immediately placing them on ice. Preparation of the cell suspensions for radioactive counting was as previously described (10, 11) . The percentage of organisms associated with the cells could be calculated by dividing cell-associated counts per minute by the counts per minute in the original inoculum and multiplying by 100. Similarly the number of bacteria associated with the cells could be obtained from calculations of the specific activity of the radiolabeled organisms.
On several occasions, the bactericidal and phagoeytosis assays were run simultaneously with the same inoculum. In experimental and control suspensions, the fraction of bacteria associated with the cells that were killed could thus be calculated. All the experiments were run in duplicate, as well as simultaneous cell-free controls.
Myeloperoxidase-mediated protein iodination. After incubation of bacteria with cells, the fixation of inorganic iodide to a trichloracetic acid-precipitable form was measured as previously described (12) . The incubation conditions were similar to those in which the bactericidal assays were performed, Morphological differences between the penicillintreated bacteria and the control were observed as previously reported (13) . The treated bacteria were larger, by phase-contrast and electron microscopy, and the cross walls of dividing organisms were thicker ( In the studies using 14C-amino acid labeling of bacteria, it was noted that penicillin-treated organisms had a significantly higher mean number of "4C counts per minute per 106 bacteria (82.5) than untreated organisms (49.8, n = 13, P < 0.05), presumably reflecting reduced divisions of the treated staphylococci. Quantitatively similar results were found when the organisms were grown in the presence of ["4C]uracil, although the labeling was higher than with '4C-amino acids (a mean 73.1 and 300 cpm/106 bacteria for untreated and penicillin-treated organisms, respectively, n = 5, P < 0.01).
Effect of pretreatment with sub-MIC penicillin and gentamicin on killing of S. aureus by normal PMN. In preliminary bactericidal assays with normal cells, incubation periods varied between 35 (Fig. 3) .
Effect of lysostaphini on? cotntrol anid pen2icillini-pretreated bacteria. Penicillin treatment of grampositive cocci alters peptidoglycan structure and augments the suseeptibility of the cell wall to attack by endogenous hydrolytic enzymes (2, 14) . Lysostaphin is a mixture of hydrolases with peptidase, amiiidase, and glycosidase activities specific for the peptidoglycan of S. aureus (15) . It Interaction between Antibiotics and Human Neutrophils rates of killing of both normal and penicillin-treated S. aureus (Fig. 5) . The percent reduction in killing of the penicillin-treated bacteria by cytochalasin B cells (a mean 26% at 30 min) was significantly less than that of the control bacteria (a mean 67%, P < 0.01).
In the presence of cytochalasin B, over twice as many penicillin-treated organisms as control were killed at 30 min (Table II) antibiotic with a different site of action than penicillin or a ribosomally active compound had any effect on killing of S. aureus by PMN. Organisms were preincubated with 1/4 MIC vancomycin or gentamicin and the results of killing by cytochalasin B cells compared with penicillin-treated and control bacteria (Table II) . As with penicillin, pretreatment with vancomycin enhanced susceptibility to killing, whereas gentamicin-pretreated organisms were killed less effectively than control.
Relationship of bacterial inoculum size to fraction killed. In these experiments with cytochalasin B PMN, the initial bacterial inoculum was not equalized for the number of viable organisms; thus, the number of viable bacteria incubated with the cells was significantly less for penicillin-pretreated than control organisms. To determine if such differences might affect the fraction of bacteria killed, bactericidal assays were performed in parallel with control and penicillin-pretreated S. aureus at different bacteriato-cell ratios. As noted by others (16), the fraction of bacteria killed remained essentially the same at bacteria/cell ratios ranging from 2.5/1 to 10/1 and significantly more penicillin-pretreated organisms were killed at each ratio (data not shown).
Dose-response relationship between vancomycin and penicillin pretreatment and enhanced killing by cytochalasin B-treated PMN. When the concentration of penicillin or vancomycin used in the preincubation was twofold serially reduced, a statistically significant increase in killing of the treated S. aureus was present in concentrations of the antimicrobials equal to 1/8 the respective MIC (Table III) , but killing continued to be greater to ½16 the MIC for the penicillin-pretreated bacteria.
In another series of experiments, the time of exposure of staphylococci to penicillin (1/4 MIC) was varied between 15 min and 4 h. Enhancement of killing by exposure to this concentration of penicillin was observed with as little as 1 h pretreatment (data Requirement for specific activity of penicillin to enhance killing. To be certain that the penicillin effects were mediated by the specific action ofthe antibiotic on the bacteria, incubations were performed in the presence of penicillinase. No enhancement of killing occurred when penicillinase (0.031 U) was added to the medium during the pretreatment phase with penicillin (a mean 36.6±5.6% killed at 30 min vs. 60.2±2.5%, no penicillinase, n = 5, P < 0.05, t test).
Untreated bacteria were killed at equivalent rates with or without penicillinase (a mean 37.8 and 38.8%, respectively).
Temperature dependence of penicillin and PMN effects. To determine if temperature-dependent steps were required for the action of the antibiotic on the bacteria as well as the cells on the organisms, the incubation conditions were varied: either the organisms were exposed to penicillin at 4°C, or organisms pretreated in the usual fashion were incubated with cytochalasin B-treated cells at 40C. The penicillin effect was lost when the organisms were pretreated at 40C and then incubated with cells at 37°C. Similarly, when the bacteria were exposed to penicillin at 370C, but added to cells kept at 40C, a minimal reduction in the initial colony count occurred and no significant difference was observed in the killing of untreated and treated bacteria (Fig. 6) .
Requirementfor binding ofbacteria to cytochalasin B-treated cells to promote killing. Staphylococci Interaction between Antibiotics and Human Neutrophilspretreated with cell wall-active antibiotics were effectively killed by cytochalasin B PMN despite reduced phagocytosis (17); however, it was not clear from the experimental design whether killing was occurring in the suspending medium or if there was a requirement for intimate contact between the organisms and the cells. To answer this question, opsonizing serum was removed from the medium. No binding of '4C-tagged organisms to cytochalasin Btreated cells took place in the absence of serum (data not shown); similarly no killing of either control or penicillin-treated bacteria occurred in serum-free suspensions (Fig. 7) . Furthermore, when intact cells were destroyed by sonication, no killing occurred even in the presence of serum.
The need for this type of contact and its specificity for presumed opsonin receptors on the PMN surface were supported by two additional experiments. In one, bacteria and cells were incubated together in a pellet created by centrifuging the mixtures at 150 g for 5 min. In the other, the cells were induced to release°2 and H202, as well as to degranulate their specific granules into the incubation medium by the addition of PMA (18, 19) . Killing did not occur in either set of conditions in the absence of opsonically active serum (Table IV) . 8 Relationship between the cell association ("binding") and killing at 30 min of S. aureus 502A by cytochalasin B-treated PMN after growth of bacteria for 2 h in TSB alone or in TSB containing Y4 MIC penicillin. The results are the mean+SEM of eight experiments. "Binding" was measured using bacteria labeled with '4C-amino acids (see Methods).
Stimulation ofPMN-myeloperoxidase-mediated protein iodination. The rate of bacterial killing by PMN parallels the rate ofphagocytosis, as does the metabolic activity of the cells (3, 11, 12, 16, 17) . Having demonstrated that the rates of phagocytosis (for normal PMN) and binding (for cytochalasin B cells) were not affected by penicillin pretreatment ofthe bacteria, we measured the stimulation of myeloperoxidase-H202-mediated protein iodination by the cells. No difference in the quantity of iodide fixed to protein was found in PMN incubated in 10% serum-HBSS with normal vs. penicillintreated bacteria (0.138+0.09 vs. 0.159+0.01 nmol/2.5 x 106 PMN per 30 min, respectively, mean+SEM of three experiments).
Lack of direct effects of penicillin on PMN functions. The addition of up to 10 times the MIC (0.75 U/ml) ofpenicillin to the medium did not alter the phagocytosis of heat-killed S. aureus by normal (6.35 vs. 63.8%) or cytochalasin B-treated cells (39.3 vs. 35 .6% uptake at 30 min in the absence and presence ofpenicillin, respectively, n = 2). Similar concentrations ofpenicillin did not affect the rate of H202 released during ingestion of S. aureus by normal or cytochalasin Btreated cells, nor the percentage of C. albicans killed after a 60-min incubation (29.0 vs. 29.3%, no penicillin vs. penicillin in the medium, respectively, n = 1).
Ultrastructural features of bacteria incubated with cells. Killing of staphylococci by penicillin can be associated with lysis of the organisms (1, 2) . To see ifmorphological changes consistent with lysis occurred in bacteria incubated with the cytochalasin B PMN, transmission electron micrographs of suspensions incubated from 5 to 60 min were compared. Beyond the initial structural changes induced by penicillin, no differences were observed between control and penicillin-treated bacteria to suggest earlier lysis of the latter. Indeed, little evidence of lysis of cell walls in either preparation was observed through 30 min incubation (Fig. 9) . DISCUSSION Several reports have appeared describing the interaction ofantimicrobials with leukocytes in the killing of bacteria. Gentamicin (21, 22) and several tetracyclines (23) may inhibit chemotactic responses of PMN, but their ability to modify phagocytosis and killing has not been reported. Intracellular staphylococci are protected from the action of,3-lactams, vancomycin, aminoglycosides, and a variety of other antimicrobials except rifampin (24) . This has formed the basis of assays of leukocyte bactericidal activity, in which extracellular organisms are selectively killed by addition of antibiotics (25) . In one such study it was observed that addition of penicillin in MIC or greater concentrations to susceptible organisms before incubation with PMN augmented the killing process (26) . From this experimental design, however, it was difficult to distinguish between any separate effects of the antibiotics vs. the PMN on the bacteria. When initiating our studies, we were stimulated by a report that pretreatment of staphylococci with nafcillin accelerated their subsequent phagocytosis by mouse macrophages (27) and that the use of sub-MIC penicillin increased the susceptibility of staphylococci to killing by mixtures of lysozyme and trypsin (28) or to lysosomal extracts (29) .
We chose to pretreat the staphylococci with concentrations of the antibiotics that were subinhibitory with respect to growth and viability. This choice was based upon two observations: (a) sub-MIC antibiotics may produce measureable morphological changes in bacteria in vitro without importantly affecting viability (13, 30) ; and (b) such concentrations and morphological alterations may be found at tissue sites of infection in vivo (31, 32) .
When organisms are treated with subinhibitory concentrations of antibiotics, the primary action of which is to inhibit protein synthesis, the rate of division is slowed and preceeded by a prolonged lag phase (33, 34) . Abnormally thick walls may be observed with some bacteria, including staphylococci (6, 13 are particularly characteristic of staphylococci exposed to subinhibitory concentrations of the penicillins and were seen after 2 h incubation of S. aureus 502A with 1/4 MIC penicillin G in the present studies. When incubation of staphylococci with sub-MIC penicillins is prolonged, then very large multiseptate organisms have been described (13) , a morphologic feature not observed with our incubation conditions. As drug concentrations approach the MIC, a progressive loss of viability (i.e., ability to replicate) has been observed (30) . In our studies, use of 1/4 MIC penicillin G for most experiments resulted in an average 30% inhibition of growth, although in some experiments growth over a 2-h period was equal to untreated controls. The decreased number of cell divisions in the presence of penicillin was reflected by a greater accumulation of '4C-amino acids and ['4C]uracil per organism when specific activities were calculated. When the organisms were removed from the antibiotic or when penicillinase was added, no further inhibition of growth was noted. This is consistent with the reversible nature of penicillin effects on cell wall synthesis at these low concentrations, as reported by others (2, 6) . Although not measured in our studies, exposure of the staphylococci to low concentrations ofthe cell wallactive drugs might be expected to cause release ofsome bacterial surface macromolecules (2, 35) . Similar data are not available for the aminoglycosides, represented in our studies by gentamicin.
By pretreating staphylococci with the antibiotics before exposing them to the PMN, we were able to distinguish between effects of the antibiotics on the bacteria and effects of the PMN on control and treated organisms. The results indicate that when cell wall-active drugs are employed in the pretreatment period, the susceptibility of S. aureus 502 A to killing by PMN is appreciably enhanced. Normal PMN killed -10% more bacteria over a relatively brief, but definitive incubation period; almost sevenfold fewer intracellular penicillin-pretreated organisms were recovered from normal PMN when lysostaphin was added to the medium. The enhanced killing was not a function of increased rates of phagocytosis.
The (15, 36) proved to be more active in killing penicillinpretreated than untreated S. aureus at low concentrations (0.1 U/ml), this posed the possibility of artifact in the measurement of intracellular survival of organisms after the addition of lysostaphin to the medium. To avoid the use of lysostaphin and to determine if susceptibility to killing by pretreatment with cell wallactive antibiotics was so enhanced that it could be observed even when phagosome formation was inhibited, experiments were conducted using cytochalasin B. Cytochalasin B is known to retard the ingestion phase of phagocytosis while permitting the binding of organisms to the cell surface (17, 37, 38) . In the presence ofcytochalasin B, the uptake ofopsonized "4C-S. aureus by PMN was inhibited by -40%, a finding similar to our previously published studies (17) . Killing of untreated S. aureus was inhibited even more strikingly (>65%) in the presence of cytochalasin B, a finding noted by others (37, 38) . In contrast, cytochalasin Btreated PMN killed penicillin-pretreated S. aureus surprisingly well, with the net result that over twice as many pretreated as untreated S. aureus were killed by PMN in the presence of cytochalasin B. When another cell wall-active antibiotic, vancomycin, with a different mode of action (39) , was used for pretreatment, similar results were found. Treatment of organisms with sub-MIC gentamicin, an antibiotic without known ability to modify the bacterial cell surface (40) , not only had no enhancing effect on killing by cytochalasin B-exposed PMN, but actually inhibited it, for reasons that remain unclear.
Conditions for the enhancement of killing by pretreatment with cell wall-active antibiotics were established. As (18, 19) . Opsonizing serum was essential to promote the killing effect under all conditions examined, indicating that the organisms had to bind to opsonin receptors (20) on the cells or be ingested to trigger the bactericidal response. When simultaneous studies of bacterial cell association and killing were carried out using radioactive labels of bacterial proteins or nucleic acids, it was determined that penicillin (and presumably vancomycin) acted by increasing the susceptibility of staphylococci to leukocyte bactericidal mechanisms, rather than by improving opsonization or the uptake of bacteria by the cells. In fact, the data indicate that virtually all cell-associated, penicillin-pretreated staphylococci were killed by cytochalasin B PMN compared with only a fraction of those not pretreated.
The increased killing of penicillin-treated bacteria was not due to enhanced cellular responses as measured by myeloperoxidase-H202-mediated protein iodination. Furthermore, incubation of the PMN in up to 10 times the amount of penicillin used for pretreatment of bacteria did not nonspecifically increase PMN phagocytic or metabolic activities, alter the PMN responses to cytochalasin B, or promote killing of a nonpenicillin-susceptible organism, C. albicans.
The precise mechanism(s) by which pretreatment of staphylococci with cell wall-active antibiotics augments their susceptibility to killing by PMN remains to be determined. The antibiotic and PMN effects could be independent (affecting differing loci) or interdependent and perhaps sequential in their action. Transmission electron microscopy showed little evidence of lysis of either the control or penicillin-treated staphylococci after 60 min incubation (a time at which most of the bacteria were dead). Thus, a lytic killing mechanism by the PMN similar to that of penicillin seems unlikely. The fact that antibiotic enhancement of killing was not reproduced by a drug that acts at the level of the bacterial ribosome, suggests that surface characteristics of organisms are important in regulating susceptibility to killing by PMN. We have subsequently obtained evidence that modification of the surface of staphylococci by pretreatment with cell wall-active antibiotics increases their susceptibility to the nonoxidative as opposed to the oxidative killing mechanisms of PMN (4, 41) . Furthermore, these observations have now been extended to other pathogenic strains of staphylococci (including those that produce 83-lactamase), other antimicrobial compounds with a similar mechanism of action (42) and to pneumococci and other streptococci (43) . Finally, the lytic arm of complement does not appear to participate in the enhanced killing of penicillin-pretreated S. aureus (44) . Detailed reports of these findings are being prepared.
In conclusion, we have demonstrated a cooperative effect between the antimicrobial properties of PMN 
